West Point Pharmaceutical: Shareholders holding more than 5% and their concerted action parties reduce their holdings by 1.1157 million shares.

West Point Pharmaceutical announced that shareholders holding more than 5%, Hengqin Dingdian and its concerted action person Zhuhai Hengqin Runhuiyi, will collectively reduce their holdings by 1,115,700 shares through centralized bidding and block trading from April 17 to July 16, 2026, accounting for 1.4779% of the company's total share capital. After the reduction, they collectively hold 6,079,897 shares, accounting for 8.0534% of the company's shares, still ranking as shareholders holding more than 5% of the company. This reduction did not result in a change in control of the company and will not affect the company's governance and operations.